Clovis Oncology, Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
Clovis Oncology, Inc. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2021-06-30, per its 10-Q filed 2021-08-04.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2021-08-04
- 2021-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2021-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2021-06-30 | $0.00 10-Q · filed 2021-08-04 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-26 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-02 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 |